Published in Lancet on May 22, 2004
Pain management strategies for neuropathic pain in Fabry disease - a systematic review. BMC Neurol (2016) 1.37
Fabry disease in children and the effects of enzyme replacement treatment. Eur J Pediatr (2009) 0.86
Fabry disease, respiratory symptoms, and airway limitation - a systematic review. Eur Clin Respir J (2015) 0.75
The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet (1999) 4.77
Endoscopic closure of esophageal intrathoracic leaks: stent versus endoscopic vacuum-assisted closure, a retrospective analysis. Endoscopy (2013) 2.08
PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature (1997) 2.08
Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. Ann Neurol (2000) 2.01
Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients. Pediatr Res (1989) 1.67
Clinical and neuropsychological outcome in 33 patients with biotinidase deficiency ascertained by nationwide newborn screening and family studies in Austria. Eur J Pediatr (2001) 1.50
Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet (1999) 1.46
Non-invasive magnetic resonance imaging of coronary bypass grafts. comparison of the haste- and navigator techniques with conventional coronary angiography. Int J Cardiovasc Imaging (2002) 1.41
Importance of calibration for diameter and area determination by intravascular ultrasound. Int J Card Imaging (1996) 1.41
[Prospective feasibility study of chest X-ray vs. thoracic MRI in breath-hold technique at an open low-field scanner]. Rofo (2002) 1.39
Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Catheter Cardiovasc Interv (1999) 1.39
Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation. Proc Natl Acad Sci U S A (1980) 1.33
Pipecolic acid as a diagnostic marker of pyridoxine-dependent epilepsy. Neuropediatrics (2005) 1.27
Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet (2001) 1.23
Pharmacologic differentiation between endothelium-dependent relaxations sensitive and resistant to nitro-L-arginine in coronary arteries. J Cardiovasc Pharmacol (1994) 1.21
Assessment of left ventricular function and mass in patients undergoing computed tomography (CT) coronary angiography using 64-detector-row CT: comparison to magnetic resonance imaging. Acta Radiol (2007) 1.17
Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann Neurol (2001) 1.15
Lipoprotein Lp(a). A risk factor for myocardial infarction. Arteriosclerosis (1988) 1.14
Mental retardation and behavioral problems as presenting signs of a creatine synthesis defect. Ann Neurol (2000) 1.11
Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses. J Inherit Metab Dis (2005) 1.10
Polytopic anomalies with agenesis of the lower vertebral column. Am J Med Genet (1999) 1.06
Acute myocardial infarction occurring in versus out of the hospital: patient characteristics and clinical outcome. Maximal Individual TheRapy in Acute Myocardial Infarction (MITRA) Study Group. J Am Coll Cardiol (2000) 1.03
Frequency of Fabry disease in patients with small-fibre neuropathy of unknown aetiology: a pilot study. Eur J Neurol (2010) 1.01
Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis. Am Heart J (2001) 1.00
The clinical spectrum of mitochondrial disease in 75 pediatric patients. Clin Pediatr (Phila) (2003) 1.00
BRCA1/2 testing: uptake, phenocopies, and strategies to improve detection rates in initially negative families. Clin Genet (2011) 0.99
Quantitative and qualitative assay of amniotic-fluid acetylcholinesterase in the prenatal diagnosis of neural tube defects. Hum Genet (1981) 0.99
Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature. J Inherit Metab Dis (2007) 0.98
Pyridoxine-dependent epilepsy: normal outcome in a patient with late diagnosis after prolonged status epilepticus causing cortical blindness. Neuropediatrics (2009) 0.96
Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease. J Inherit Metab Dis (2006) 0.96
125th anniversary of the Institute of Neurology (Obersteiner Institute) in Vienna. "Germ Cell" of interdisciplinary neuroscience. Clin Neuropathol (2009) 0.96
Long-term outcome of patients with argininosuccinate lyase deficiency diagnosed by newborn screening in Austria. Mol Genet Metab (2010) 0.95
Changes of tissue creatine concentrations upon oral supplementation of creatine-monohydrate in various animal species. Life Sci (2001) 0.95
Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism. J Inherit Metab Dis (2003) 0.95
Morquio disease in a patient diagnosed as having Perthes disease for 38 years. J Inherit Metab Dis (1995) 0.94
Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses. J Inherit Metab Dis (2005) 0.94
Immunohistochemical detection of cell growth fraction in formalin-fixed and paraffin-embedded murine tissue. Am J Pathol (2001) 0.93
Mucopolysaccharidosis IVA: identification of mutations and methylation study in GALNS gene. J Med Genet (2004) 0.92
Differences in the morphology of unstable and stable coronary lesions and their impact on the mechanisms of angioplasty. An in vivo study with intravascular ultrasound. Eur Heart J (1996) 0.91
Enzymic diagnosis of the genetic mucopolysaccharide storage disorders. Methods Enzymol (1982) 0.91
Clinical heterogeneity in Sanfilippo disease (mucopolysaccharidosis III) type D: presentation of two new cases. Eur J Pediatr (1983) 0.90
Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype. Neuropediatrics (2003) 0.90
Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo. J Neuropathol Exp Neurol (2001) 0.90
Evidence for oxidative stress in experimental prion disease. Neurobiol Dis (2000) 0.90
Photosensitized killing of cultured fibroblasts from patients with peroxisomal disorders due to pyrene fatty acid-mediated ultraviolet damage. J Clin Invest (1991) 0.90
Noninvasive coronary angiography using 64-detector-row computed tomography in patients with a low to moderate pretest probability of significant coronary artery disease. Acta Radiol (2007) 0.89
A new thrombectomy catheter device (AngioJet) for the disruption of thrombi: An in vitro study. Catheter Cardiovasc Interv (1999) 0.88
Infantile type of sialic acid storage disease with sialuria. Clin Genet (1986) 0.88
Human parvovirus B19 infection associated with severe acute perimyocarditis in a 34-year-old man. Eur Heart J (1997) 0.87
High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease. J Inherit Metab Dis (2005) 0.86
Molecular characterisation of 34 patients with biotinidase deficiency ascertained by newborn screening and family investigation. Eur J Hum Genet (2001) 0.86
Phenotype determining alleles in GM1 gangliosidosis patients bearing novel GLB1 mutations. Clin Genet (2010) 0.86
Morquio syndrome (mucopolysaccharidosis IV B) associated with beta-galactosidase deficiency. Report of two cases. Am J Hum Genet (1980) 0.86
[Cardio-MRT. The multimodal functional analysis of the future]. Z Kardiol (2004) 0.86
The renin-angiotensin system in the brain. Localization and functional significance. Arzneimittelforschung (1993) 0.85
Selective neuronal vulnerability in human prion diseases. Fatal familial insomnia differs from other types of prion diseases. Am J Pathol (1999) 0.85
Ellis-van Creveld syndrome: a generalized dysplasia of enchondral ossification. Pediatr Radiol (2001) 0.84
Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation. Circulation (1998) 0.84
[Genetic amniocentesis: technique and results in 1,000 first trimester amniocenteses (author's transl)]. Geburtshilfe Frauenheilkd (1980) 0.84
Telencephalosynapsis (synencephaly) and rhombencephalosynapsis with posterior fossa ventriculocele ('Dandy-Walker cyst'): an unusual aberrant syngenetic complex. Brain Dev (1997) 0.84
Recombinant growth hormone therapy in patients with ischemic cardiomyopathy : effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. Circulation (1999) 0.84
Cardiac output in single-lead VDD pacing versus rate-matched VVIR pacing. Am J Cardiol (1995) 0.83
Sanfilippo type D disease: clinical findings in two patients with a new variant of mucopolysaccharidosis III. Eur J Pediatr (1982) 0.83
Multiple forms of 2-deoxy-D-glucoside-2-sulphamate sulphohydrolase from human placenta. Biochem J (1979) 0.83
Mutation analysis in glycogen storage disease type 1 non-a. Hum Genet (2000) 0.83
Sanfilippo's disease type A: sulfamidase activity in peripheral leukocytes of normal, heterozygous and homozygous individuals. Clin Chim Acta (1977) 0.82
Low alpha-fetoprotein and serum albumin levels in Morbus Down may point to a common regulatory mechanism. Hum Genet (1985) 0.82
Creatine deficiency syndromes: a new perspective on metabolic disorders and a diagnostic challenge. J Pediatr (1997) 0.82
Is there a risk for interaction between mobile phones and single lead VDD pacemakers? Pacing Clin Electrophysiol (1996) 0.81
[Early treatment of acute myocardial infarct: implementation of therapy guidelines in routine clinical practice, MITRA pilot phase]. Z Kardiol (1997) 0.81
Guanidinoacetate methyltransferase (GAMT) deficiency: non-invasive enzymatic diagnosis of a newly recognized inborn error of metabolism. Clin Chim Acta (2000) 0.81
Demonstration of astrocytes in cultured amniotic fluid cells of three cases with neural-tube defect. Hum Genet (1981) 0.81
[Perfusion MR imaging of the heart with TrueFISP]. Rofo (2001) 0.81
Homocystinuria due to cystathionine beta-synthase deficiency: novel biochemical findings and treatment efficacy. J Inherit Metab Dis (2003) 0.81
Guanidinoacetate methyltransferase deficiency: differences of creatine uptake in human brain and muscle. Mol Genet Metab (2004) 0.81
Contrast-enhanced three-dimensional MR angiography of the thoracic aorta: experiences after 118 examinations with a standard dose contrast administration and different injection protocols. Eur Radiol (2001) 0.80
Is left ventricular hypertrabeculation/ noncompaction a cardiac manifestation of Fabry's disease? Z Kardiol (2003) 0.80
Late improvement of regional wall motion after the subacute phase of myocardial infarction treated by acute PTCA in a 6-month follow-up. J Cardiovasc Magn Reson (2003) 0.80
A family with visceral course of Niemann-Pick disease, macular halo syndrome and low sphingomyelin degradation rate. J Inherit Metab Dis (1994) 0.80
Degradation of keratan sulphate by beta-N-acetylhexosaminidases A and B. Biochem J (1981) 0.80
Factors involved in the pathogenesis of unexpected near miss events of infants (ALTE). Acta Paediatr Hung (1990) 0.80
[Use of coronary angiography after acute myocardial infarction in Germany: a comparison of daily clinical practice with international guidelines. MITRA Study]. Z Kardiol (1999) 0.79
Nuclear magnetic resonance spectroscopy in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 0.79
Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome? Acta Paediatr (2005) 0.79
In vitro evaluation of coronary stents and in-stent stenosis using a dynamic cardiac phantom and a 64-detector row CT scanner. Clin Res Cardiol (2007) 0.79
Energy metabolism in graded perinatal asphyxia of the rat. Life Sci (2000) 0.79
Farber lipogranulomatosis type 1--late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation. Eur J Paediatr Neurol (2010) 0.79
Hormonal profile and fertility in patients with Anderson-Fabry disease. Int J Clin Pract (2005) 0.79
How reliable is atrial sensing in single-lead VDD pacing: comparison of three systems. Pacing Clin Electrophysiol (1998) 0.79
Hyperhomocysteinemia in children with juvenile idiopathic arthritis is not influenced by methotrexate treatment and folic acid supplementation: a pilot study. Clin Exp Rheumatol (2003) 0.78
Morquio disease, type B: activation of GM1-beta-galactosidase by GM1-activator protein. Biochem Biophys Res Commun (1982) 0.78
Effects of oral creatine supplementation in a patient with MELAS phenotype and associated nephropathy. Neuropediatrics (2002) 0.78
First experience with an automatic sensing algorithm in single-lead VDD stimulation. Pacing Clin Electrophysiol (1998) 0.78
Characterization of seven novel mutations in seven patients with GAMT deficiency. Hum Mutat (2004) 0.78
A novel 6 bp insertion in exon 7 associated with an unusual phenotype in a family with Fabry disease. J Inherit Metab Dis (2002) 0.78